SCHEMBL9941296

SCHEMBL9941296

O=C(NC(Cc1ccc(-c2ccccc2)cc1)CC(O)C(=O)O)c1cnc2[nH]nnc2c1

nearest known ligand 0.72

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 20/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9930053 1.00 MME (0.72) MME
SCHEMBL9930386 1.00 MME (0.72) MME
SCHEMBL9930017 0.89 MME (0.62) MME
SCHEMBL9929946 0.89 MME (0.62) MME
SCHEMBL9941029 0.89 MME (0.62) MME
SCHEMBL9930270 0.87 MME (0.76) MME
SCHEMBL9930272 0.87 MME (0.76) MME
SCHEMBL9929617 0.87 MME (0.75) MME
SCHEMBL9929619 0.87 MME (0.75) MME
SCHEMBL9930131 0.86 MME (0.74) MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651896-A1 NEPRILYSIN INHIBITORS Theravance, Inc. (US) 2013-10-23 — — EP disclosed
WO-2012082853-A1 NEPRILYSIN INHIBITORS THERAVANCE, INC. (US) 2012-06-21 — — WO disclosed
Send feedback